Covidien (COV +2.2%) trades higher after announcing the FDA has issued a clearance for the...

|By:, SA News Editor

Covidien (COV +2.2%) trades higher after announcing the FDA has issued a clearance for the company's SpiderFX, an embolic protection device for the treatment of severely calcified arterial lesions in the lower extremities.